Cytomegalovirus IgG in HIV+ persons on anti-retroviral therapy: characterisation and association with insulin resistance

Samantha Jane Brunt

    Research output: ThesisMaster's Thesis

    258 Downloads (Pure)

    Abstract

    Evidence suggests latent cytomegalovirus (CMV) infection may increase risk of chronic disease in HIV-infected persons on anti-retroviral therapy (ART). This work explored CMV-specific antibodies (IE-1, gB and lysate ant1gens) as a biomarker for cardiovascular disease, neurocognitive impairment or insulin resistance in Australian HIV cohorts. Levels of autoantibody, total antibody and inflammatory markers were characterised in longitudinal and cross-sectional studies. A novel association between cytomegalovirus antibody and insulin resistance was found, independent of CD4 T-cell depletion, total antibody level and ageing. The findings suggest elevated CMV antibody levels may be indicative of developing insulin resistance in HIV patients on ART.
    Original languageEnglish
    QualificationMasters
    Awarding Institution
    • The University of Western Australia
    Supervisors/Advisors
    • D'Orsogna, Lloyd, Supervisor
    • Lee, Silvia, Supervisor
    • Price, Patricia, Supervisor
    Award date16 Aug 2016
    Publication statusUnpublished - 2016

    Fingerprint

    Dive into the research topics of 'Cytomegalovirus IgG in HIV+ persons on anti-retroviral therapy: characterisation and association with insulin resistance'. Together they form a unique fingerprint.

    Cite this